Research & Development



  雲瑯大笑道︰“這是何公愛我之故。”   一個懶洋洋的聲音從柱子後面傳來︰“當年莊子曰,聖人不死,大盜不絕,里面的聖人說的就是你儒家吧?而且,老子曰的︰棄智絕聖,敢為奇者,吾將執而殺之,說的也是你儒家吧。怎麼,公孫丞相準備自戕嗎?”青娱乐视频首页   雲瑯听阿嬌這樣說,心頭的石塊變得越發沉重了,也不知道劉徹的信心是從哪里來的。青娱乐qingyule   陳昆抬頭看著眼前的醫館,眼前的樓閣之高,需要不斷地抬頭,才能看的齊全,直到帽子墜地,他才清醒過來,難以置信的指著眼前的這座四層樓閣道︰“這就是宋師妹的醫館?”   “您剛才的模樣比詛咒可怕的太多了。”青娱乐在线品盛宴   一年後,璇璣城長老藥婆,女弟宋喬下山尋找甦稚,亦被軍司馬雲瑯接納,後迎娶宋喬為妻。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo